SHP Wealth Management’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$562 Hold
25
﹤0.01% 1601
2025
Q4
$445 Buy
+25
New +$315 ﹤0.01% 1384

Other funds holding ANRO

SHP Wealth Management's ANRO Position: Q1 2026 in Review

SHP Wealth Management held its Alto Neuroscience (ANRO) position steady in Q1 2026 at 25 shares worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

SHP Wealth Management first reported a position in ANRO in Q4 2025 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • SHP Wealth Management held 25 shares of Alto Neuroscience worth $562 as of Q1 2026.
  • SHP Wealth Management left its Alto Neuroscience share count unchanged in Q1 2026.
  • Alto Neuroscience made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #1601 holding.
  • SHP Wealth Management first reported a position in Alto Neuroscience in Q4 2025 and has held it in 2 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.